Medicamen Biotech Limited
Share Price Target & Analysis
NSE:MEDICAMEQ
VWAP
Open
Close
High
Low
52 Week High
5.75 (2.01%)
MEDICAMEQ
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Silver
Valuation
#Analysis
NSE: MEDICAMEQ Share Price Financial Analysis & Valuation
Medicamen Biotech Limited (MEDICAMEQ) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of SME Stocks company with Market Capitalization of Rs 78290.1 (in Cr). Total number of free float shares are 0 (in Lacs).
Medicamen Biotech Limited is listed on NSE with Exchange ID - INE646B01010 and trading code is NSE:MEDICAMEQ with short name Medicamen Bio.
In the past 1 year, Medicamen Biotech Limited has declared an equity dividend of Rs 0 per share. At the current share price of MEDICAMEQ at Rs 291.50, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:MEDICAMEQ, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine MEDICAMEQ underlying value and future prospects. All of this data is available in MEDICAMEQ financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:MEDICAMEQ, it is clearly understood that MEDICAMEQ is Economical performer in terms of earnings and profit margins with an EPS of 12.15. NSE:MEDICAMEQ book value per share as of today is 208.08. The current price to book ratio for MEDICAMEQ as of Sep 09, 2026 is 1.4.
Valuation of the Stock: The current valuation of MEDICAMEQ stock is like Silver which means currently the stock is at Premium. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of MEDICAMEQ whether to BUY this stock at current valuation. The delivery percentage of MEDICAMEQ is 33577% is very crucial parameter which shows that 33577% investors are anticipating that the price of MEDICAMEQ share should go up with VWAP at 286.23.
Now, the main question is whether to BUY or SELL, NSE:MEDICAMEQ at current valuation.
As per latest Analysis No. #1560:-
⇑ STRONG BUY MEDICAMEQ if All Greens
⇗ BUY MEDICAMEQ (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD MEDICAMEQ (With Stop Loss) if only 1 Green
⇘ SELL MEDICAMEQ if NO Green Indicator
NSE: MEDICAMEQ Share Price Today (Sep 09, 2026)
(Medicamen Biotech Limited Daily Analysis on the basis of MEDICAMEQ Intraday Graph & Trend)
Medicamen Biotech Limited share price moved Up by 2.01% from its previous close of Rs 285.75. MEDICAMEQ stock last traded price is 291.50. MEDICAMEQ share price trend is Up with a total of 38539 stocks traded till now. It has touched an intraday high of Rs 292.4 and an intraday low of Rs 280.05. The MEDICAMEQ trading at 291.50, Up by Rs. 5.75, or 2.01 percent which suggests that most of the Traders are anticipating that the price of MEDICAMEQ share should go Up.
NSE: MEDICAMEQ Share Price Tomorrow Prediction
(Medicamen Biotech Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of MEDICAMEQ)
Medicamen Biotech Limited share price moved Up by 2.01%. MEDICAMEQ share price short term trend is Up. It suggests that MEDICAMEQ Share Price for Tomorrow remains the same with VWAP at 286.23 will be treated as stop loss for intraday traders. Medicamen Biotech Limited Long term investors can follow the MEDICAMEQ long term trend as mentiond in future forecast table.
NSE Code |
NSE: MEDICAMEQ |
MEDICAMEQ Share Price Today |
291.50 |
MEDICAMEQ Share Price Target Prediction for 2026 ^ |
222.7 - 350.7 |
MEDICAMEQ Share Price Target Prediction for 2027*^ |
350.7 - 479.3 |
MEDICAMEQ Share Price Target Prediction for 2028*^ |
479.3 - 512.9 |
MEDICAMEQ Share Price Target Prediction for 2029*^ |
539 |
MEDICAMEQ Share Price Target Prediction for 2030*^ |
554 |
MEDICAMEQ Share Price Target Prediction for 2035*^ |
604 |
| MEDICAMEQ Current Book Value |
207 |
*Medicamen Biotech Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^MEDICAMEQ share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
MEDICAMEQ Technical Analysis
Candlestick Pattern: @267.4| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 249.83 | BUY | 253.95 | BUY |
| MA_12 | 240.29 | BUY | 245.14 | BUY |
| MA_20 | 239.68 | BUY | 242.89 | BUY |
| MA_32 | 240.01 | BUY | 242.06 | BUY |
| MA_50 | 241.67 | BUY | 243.46 | BUY |
| MA_100 | 249.08 | BUY | 252.18 | BUY |
| MA_200 | 297.19 | SELL | 287.28 | SELL |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 260.89 | OverBought |
| MACD | 3.44 | BUY |
| ADX | 12.15 | NO or Weak Trend |
| DMI (+/-) | 31.43 / 15.64 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 64.03 | Neutral |
| STOCHASTIC_K (Fast) | 85.28 | Overbought |
| STOCHASTIC_D (Slow) | 82.52 | Overbought |
| CCI | 250.28 | BUY |
| PSAR | 217.69 | BUY |
| TRUE RANGE | 19.95 | SELL |
| ATR | 13.58 | SELL |
| WILLIAMS R | -18.12 | Overbought |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 100 | Overbought |
| STOCHASTIC RSI D | 100 | Overbought |
| MOMENTUM | 27.38 | BUY |
| Duration | Value |
|---|---|
| 1 Year | -23.62% |
| 3 Months | -1% |
| 1 Month | 11.41% |
| 1 Week | 12.38% |
| Action | Overall (%) |
|---|---|
| BUY | 77% |
| NEUTRAL / HOLD | 10% |
| SELL | 13% |
Most popular Questions & Answers about MEDICAMEQ (/ FAQ MEDICAMEQ)
Medicamen Biotech Limited stock last traded price is 291.50. MEDICAMEQ share price moved Up by 2.01% from its previous close of Rs 285.75.
Medicamen Biotech Limited share price trend is Up with a total of 38539 stocks traded till now. It has touched an intraday high of Rs 452.1265 and an intraday low of Rs 280.05. The MEDICAMEQ trading at 291.50, Up by Rs. 5.75, or 2.01 percent which suggests that most of the Traders are anticipating that the price of MEDICAMEQ share should go Up and the Stop Loss will be around 286.23.
The market cap of Medicamen Biotech Limited is ₹78290.1 (in Cr) as of Sep 08, 2026.
The current price to earning ratio for Medicamen Biotech Limited as of Sep 08, 2026 is 38.41.
The current price to book ratio for Medicamen Biotech Limited as of Sep 08, 2026 is 1.4.
The highest price of Medicamen Biotech Limited stock is ₹447.65 in the last 52-week.
The lowest price of Medicamen Biotech Limited stock is ₹212.4 in the last 52-week.
Medicamen Biotech Limited share trading at ₹291.50, Up by Rs. 5.75, or 2.01 percent which suggests that most of the traders are anticipating that the price of MEDICAMEQ share should go Up.
In 2026, Stock price target for Medicamen Biotech Limited (MEDICAMEQ) will be around ₹222.7 on downside and ₹350.7 on upside. Medicamen Biotech Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Medicamen Biotech Limited (MEDICAMEQ) will be around ₹350.7 on downside and ₹479.3 on upside. Medicamen Biotech Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Medicamen Biotech Limited (MEDICAMEQ) will be around ₹479.3 on downside and ₹512.9 on upside. Medicamen Biotech Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Medicamen Biotech Limited (MEDICAMEQ) will be around ₹554 Medicamen Biotech Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of MEDICAMEQ.
The price of Medicamen Biotech Limited (MEDICAMEQ) shares moved by 2.01%. The short-term trend for MEDICAMEQ share price is Up. It implies that the share price of MEDICAMEQ will stay the same tomorrow and that intraday traders should treat VWAP at 286.23 as a stop loss. Investors with a long-term outlook can track MEDICAMEQ long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of MEDICAMEQ stock is 145.7. Compared to the current market price of 291.50 INR, the MEDICAMEQ stock is Overvalued by 50%.
As per the fundamental analysis of Medicamen Biotech Limited (MEDICAMEQ), it is of Economical quality in terms of earnings and profit margins with an EPS of 12.15. Medicamen Biotech Limited book value per share as of today is 208.08. The current price to book ratio for MEDICAMEQ as of Sep 09, 2026 is 1.4.
NSE:MEDICAMEQ News & Other Useful Information about MEDICAMEQ Share Price
Peer Comparison of NSE: MEDICAMEQ
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1864.90 | 16.35 | 97.89 |
| DIVISLAB | 9488.00 | 115.55 | 663.06 |
| MEDICAMEQ | 291.50 | 12.15 | 208.08 |
| CIPLA | 1363.10 | 51.67 | 434.03 |
| DRREDDY | 1145.00 | 53.19 | 380.63 |
| TORNTPHARM | 4930.00 | 87.32 | 235.7 |
| BIOCON | 395.00 | 1.27 | 166.51 |
| LUPIN | 2100.00 | 154.86 | 718.37 |
| ALKEM | 5139.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1698.90 | 46.49 | 403.84 |
| ABBOTINDIA | 25225.00 | 766.11 | 2448.41 |
| GLAXO | 2890.20 | 63.65 | 147.25 |
| IPCALAB | 1963.60 | 56.72 | 329.23 |
| LAURUSLABS | 1937.00 | 20.74 | 102.57 |
| LALPATHLAB | 1919.70 | 39.68 | 157.23 |
| PFIZER | 4171.00 | 170.54 | 963.41 |
| AJANTPHARM | 3534.40 | 89.3 | 363.23 |
| SANOFI | 3104.20 | 158.05 | 332.96 |
| NATCOPHARM | 826.30 | 82.14 | 481.67 |
| APLLTD | 817.40 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2435.00 | 1.24 | 881.78 |
| AAREYDRUGS | 98.01 | 2.39 | 53.38 |
| JUBLPHARMA | 1019.00 | 4.35 | 145.63 |
| SPARC | 200.58 | 48.14 | 40.45 |
| GRANULES | 884.80 | 23.25 | 180.42 |
| ASTRAZEN | 6876.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2723.10 | 55.52 | 285.6 |
| FDC | 354.30 | 21.19 | 161.21 |
| HIKAL | 240.69 | 9.34 | 96.63 |